Trial update
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease: registry status update
The registry reports recruiting. This is trial metadata, not an assessment of treatment benefit.
Loading research and source information…
Source-dated updates from the selected studies. A recent check does not mean the registry record itself changed recently.
31 developments · Showing 13–16
The registry reports recruiting. This is trial metadata, not an assessment of treatment benefit.
The registry reports recruiting. This is trial metadata, not an assessment of treatment benefit.
The registry reports recruiting. This is trial metadata, not an assessment of treatment benefit.
The registry reports recruiting. This is trial metadata, not an assessment of treatment benefit.